Clinical Trial Update: Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 comparative bioavailability study of BAFIERTAM (monomethyl fumarate) vs Tecfidera (dimethyl fumarate) in healthy subjects; completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• BAFIERTAM (MONOMETHYL FUMARATE)
• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Banner Life Sciences LLC | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 1 | Status: COMPLETED | Results posted: 2021-07-28